Intralesional treatment of basal cell carcinoma using recombinant human alpha interferons.

摘要

Human basal cell carcinoma is successfully treated by intralesional administration of recombinant human alpha interferon, especially interferon alfa-2b. The preparation of suitable pharmaceutical compositions is disclosed.